Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4755486
Max Phase: Preclinical
Molecular Formula: C15H20ClN3O4S
Molecular Weight: 373.86
Molecule Type: Unknown
Associated Items:
ID: ALA4755486
Max Phase: Preclinical
Molecular Formula: C15H20ClN3O4S
Molecular Weight: 373.86
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC[C@@H]1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O
Standard InChI: InChI=1S/C15H20ClN3O4S/c1-4-5-11-14(21)19-15(18-11)17-10-7-6-9(16)13(12(10)20)24(22,23)8(2)3/h6-8,11,20H,4-5H2,1-3H3,(H2,17,18,19,21)/t11-/m0/s1
Standard InChI Key: VQIZKWDESWYSIJ-NSHDSACASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 373.86 | Molecular Weight (Monoisotopic): 373.0863 | AlogP: 2.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 107.86 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.31 | CX Basic pKa: 3.89 | CX LogP: 2.87 | CX LogD: 1.79 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.68 | Np Likeness Score: -0.81 |
1. Che J,Wang Z,Shen Z,Zhuang W,Ying H,Hu Y,Hu Y,Xie X,Dong X. (2021) Discovery of 1,5-Dihydro-4H-imidazol-4-one Derivatives as Potent, Selective Antagonists of CXC Chemokine Receptor 2., 12 (5.0): [PMID:34055234] [10.1021/acsmedchemlett.1c00113] |
Source(1):